Treatment Patterns, Outcomes and Costs Among Elderly Patients with Chronic Myeloid Leukaemia
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 21 (11) , 737-746
- https://doi.org/10.2165/00002512-200421110-00004
Abstract
Background and objective Chronic myeloid leukaemia (CML) affects approximately 3000–5000 Americans each year, with the American Cancer Society expecting 4600 new cases in 2004. The incidence of CML...Keywords
This publication has 41 references indexed in Scilit:
- Current CML therapy: progress and dilemmaLeukemia, 2003
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Recent Advancements in the Treatment of Chronic Myelogenous LeukemiaAnnual Review of Medicine, 2002
- Hospice Use Before DeathMedical Care, 2002
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Which terminally ill cancer patients receive hospice in-patient care?Social Science & Medicine, 1998
- Factors Associated With Surgical and Radiation Therapy for Early Stage Breast Cancer in Older WomenJNCI Journal of the National Cancer Institute, 1996
- Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at DiagnosisMedical Care, 1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992